<![CDATA[Hansa Biopharma — April 2024]]>Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance

https://www.hansabiopharma.com/media/press-releases/2024/hansa-biopharma-expects-strong-first-quarter-2024-sales-performance/

]]>https://dev.proinvestor.com/forum/topic/400749/hansa-biopharma-april-2024RSS for NodeSat, 06 Jun 2026 04:40:45 GMTTue, 02 Apr 2024 03:21:18 GMT60<![CDATA[Reply to Hansa Biopharma — April 2024 on Fri, 26 Apr 2024 03:43:53 GMT]]>Godmorgen 🙂 ja mange fine kursmål og forventninger til fremtiden men kursen flytter sig ikke kurs 27 det lå aktien i for 10 år siden tankevækkende at der intet er sket ???

]]>https://dev.proinvestor.com/forum/post/8007286https://dev.proinvestor.com/forum/post/8007286Fri, 26 Apr 2024 03:43:53 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 25 Apr 2024 06:30:23 GMT]]>Hansa Biopharma: Solid outlook

Just a moment...

favicon

(www.redeye.se)

(Redeye)

]]>https://dev.proinvestor.com/forum/post/8007282https://dev.proinvestor.com/forum/post/8007282Thu, 25 Apr 2024 06:30:23 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Mon, 22 Apr 2024 03:38:02 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8007283https://dev.proinvestor.com/forum/post/8007283Mon, 22 Apr 2024 03:38:02 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Fri, 19 Apr 2024 03:33:13 GMT]]>Godmorgen 🙂 ja kursen kommer sku ikke videre godt nok en sejtrækker kom nu med de insiderkøb der vil give investorerne tro på casen så længe ledelsen ikke vil
/ tør ja så står det meste af markedet i venteposition

]]>https://dev.proinvestor.com/forum/post/8007281https://dev.proinvestor.com/forum/post/8007281Fri, 19 Apr 2024 03:33:13 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 18 Apr 2024 09:59:54 GMT]]>Din kommentar er noteret 🙂 CC nu!

]]>https://dev.proinvestor.com/forum/post/8007279https://dev.proinvestor.com/forum/post/8007279Thu, 18 Apr 2024 09:59:54 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 18 Apr 2024 05:42:17 GMT]]>Exitnu ja ved godt tallene kom primo april dog 2 mill højere en det ud-meldte problemet er vel deres omk. og så at de ikke selv køber sig ind i casen

]]>https://dev.proinvestor.com/forum/post/8007280https://dev.proinvestor.com/forum/post/8007280Thu, 18 Apr 2024 05:42:17 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 18 Apr 2024 05:32:52 GMT]]>Ro på! Produktsalget for Q1 var kendt på forhånd. Cash-runwayen er nu forlænget ind i 2026. Det er en Hansa-Biopharma-Kursudvikling-Nedad-Classic på regnskabsdagen ... vi kan sagtens slutte langt højere.

]]>https://dev.proinvestor.com/forum/post/8007287https://dev.proinvestor.com/forum/post/8007287Thu, 18 Apr 2024 05:32:52 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 18 Apr 2024 05:20:13 GMT]]>markedet er ikke imponeret er der hår i suppen deres omk. ? og måske mangel på ledelsen selv byder ind i casen ?
ledelse

]]>https://dev.proinvestor.com/forum/post/8007276https://dev.proinvestor.com/forum/post/8007276Thu, 18 Apr 2024 05:20:13 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 18 Apr 2024 04:22:42 GMT]]>"... We expect further positive share price support."

]]>https://dev.proinvestor.com/forum/post/8007285https://dev.proinvestor.com/forum/post/8007285Thu, 18 Apr 2024 04:22:42 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 18 Apr 2024 04:21:46 GMT]]>Hansa Biopharma Q1: Improved outlook

Just a moment...

favicon

(www.redeye.se)

]]>https://dev.proinvestor.com/forum/post/8007278https://dev.proinvestor.com/forum/post/8007278Thu, 18 Apr 2024 04:21:46 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 18 Apr 2024 03:36:31 GMT]]>Godt at se der begynder at ske lidt på salgsiden 🙂

]]>https://dev.proinvestor.com/forum/post/8007284https://dev.proinvestor.com/forum/post/8007284Thu, 18 Apr 2024 03:36:31 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 18 Apr 2024 03:24:59 GMT]]>Analyst Consensus (Updated 12-04-2024) Buy: 8, Hold: 1, Sell: 0.

Link Preview Image
Analysts and consensus | Hansa Biopharma

We develop innovative immunomodulating therapies with the potential to transform the lives of people affected by rare immunologic conditions.

favicon

(www.hansabiopharma.com)

]]>https://dev.proinvestor.com/forum/post/8007272https://dev.proinvestor.com/forum/post/8007272Thu, 18 Apr 2024 03:24:59 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 18 Apr 2024 03:12:47 GMT]]>Hansa Biopharma will host a telephone conference today Thursday, April 18, 2024, 14:00 CET / 8:00am EST.

The webcast will be available on https://hansabiopharma.eventcdn.net/events/interim-report-january-march-2024

]]>https://dev.proinvestor.com/forum/post/8007274https://dev.proinvestor.com/forum/post/8007274Thu, 18 Apr 2024 03:12:47 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 18 Apr 2024 03:08:10 GMT]]>Hansa Biopharma interim report January-March 2024

https://www.hansabiopharma.com/media/press-releases/2024/hansa-biopharma-interim-report-january-march-2024/

• Strong sales performance and solid momentum with the Phase 3 trial in anti-GBM disease
• Cash runway extended into 2026
• Evan Ballantyne joins Hansa Biopharma as Chief Financial Office

]]>https://dev.proinvestor.com/forum/post/8007270https://dev.proinvestor.com/forum/post/8007270Thu, 18 Apr 2024 03:08:10 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Thu, 18 Apr 2024 02:24:36 GMT]]>God morgen 🙂

]]>https://dev.proinvestor.com/forum/post/8007268https://dev.proinvestor.com/forum/post/8007268Thu, 18 Apr 2024 02:24:36 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Wed, 17 Apr 2024 03:33:31 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8007267https://dev.proinvestor.com/forum/post/8007267Wed, 17 Apr 2024 03:33:31 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Tue, 16 Apr 2024 03:33:33 GMT]]>God morgen 🙂

]]>https://dev.proinvestor.com/forum/post/8007277https://dev.proinvestor.com/forum/post/8007277Tue, 16 Apr 2024 03:33:33 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Mon, 15 Apr 2024 03:26:21 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8007269https://dev.proinvestor.com/forum/post/8007269Mon, 15 Apr 2024 03:26:21 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Fri, 12 Apr 2024 11:10:28 GMT]]>Redeye: "We increase our base case to SEK 120 (115) with a Bull Case of SEK 220 (215) and Bear Case of SEK 15 (15)."

]]>https://dev.proinvestor.com/forum/post/8007265https://dev.proinvestor.com/forum/post/8007265Fri, 12 Apr 2024 11:10:28 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Fri, 12 Apr 2024 11:09:26 GMT]]>Hansa Biopharma: Secures growth capital supported by two solid quarters

https://www.redeye.se/research/995513/hansa-biopharma-secures-growth-capital-supported-by-two-solid-quarters

]]>https://dev.proinvestor.com/forum/post/8007271https://dev.proinvestor.com/forum/post/8007271Fri, 12 Apr 2024 11:09:26 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Fri, 12 Apr 2024 07:42:17 GMT]]>Super med nyheden om frembringelse af kapital få nu sat turbo på salget og få kursen markant højere end det leje vi ligger i nu og har gjort alt alt alt for længe 🙂

]]>https://dev.proinvestor.com/forum/post/8007264https://dev.proinvestor.com/forum/post/8007264Fri, 12 Apr 2024 07:42:17 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Fri, 12 Apr 2024 04:40:48 GMT]]>Det er super god nyhed, nu er der klarhed mht. finansieringen på den mellemlange bane.

]]>https://dev.proinvestor.com/forum/post/8007266https://dev.proinvestor.com/forum/post/8007266Fri, 12 Apr 2024 04:40:48 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Fri, 12 Apr 2024 04:30:51 GMT]]>Exitnu: Hvad tænker du positivt? Det måske er den sidste NE, godt nok på lavt niveau.

]]>https://dev.proinvestor.com/forum/post/8007260https://dev.proinvestor.com/forum/post/8007260Fri, 12 Apr 2024 04:30:51 GMT<![CDATA[Reply to Hansa Biopharma — April 2024 on Fri, 12 Apr 2024 04:27:34 GMT]]>Hansa Biopharma stärker kassan genom riktad nyemission på 372 miljoner kronor (Finwire)

https://www.placera.se/placera/telegram/2024/04/12/hansa-biopharma-hansa-biopharma-starker-kassan-genom-riktad-nyemission-pa-372-miljoner-kronor.html

"Bland investerarna som tecknat aktier finns Braidwell, Redmile Group, Fjärde AP-fonden, Sphera Healthcare, Woodline Partners, en entitet som förvaltas av Heights Capital Ireland och Maven Investment Partners."

]]>https://dev.proinvestor.com/forum/post/8007259https://dev.proinvestor.com/forum/post/8007259Fri, 12 Apr 2024 04:27:34 GMT